Weight-loss drugs among £45m of illegally traded medicines seized in 2025 Medicines and Healthcare products Regulatory Agency figures show that more than 5,000 glucagon-like peptide-1 products were seized in 2025.…
Two-prescriber sign-off no longer required for isotretinoin The Medicines and Healthcare products Regulatory Agency said that scrapping the two-prescriber requirement will address delays in access to acne treatment for patients aged under 18 years old.…
Drug consumption room pilot records more than 1,000 injecting episodes in a month According to latest service data on The Thistle, a drug consumption facility in Glasgow, 560 people used the site's services more than 10,000 times in 2025.…
Health news round-up: prescribing, deprescribing and medication considerations A weekly summary of important developments in health news that you may have missed.…
Norovirus and strategies for infection control How to recognise the signs and symptoms of norovirus infection, with an overview of pharmacy’s role in its management.…
Guild of Healthcare Pharmacists recommends ‘ring-fencing’ diamorphine stock amid supply issues Medicine supply alerts sent in December 2025 and January 2026 have requested that prescribers switch to morphine sulphate 10mg/1mL injections, where possible.…
Higher-dose Wegovy could increase patient expectation, warns PDA The Medicines and Healthcare products Regulatory Agency has approved a 7.2mg dose of Wegovy after the higher dose showed success in clinical trial patients.…
Community pharmacy cholesterol testing pilot expands across east London Under the scheme, pharmacies use a seven-minute test to assess patients’ cholesterol levels and offer an estimate of their risk of heart problems over the next ten years.…
Management of hypertrophic cardiomyopathy Pharmacological treatment approaches for hypertrophic cardiomyopathy, including pharmacogenomic considerations for first-in-class myosin inhibitors.…
Addiction warnings on opioid and z-drug packaging to be strengthened The Medicines and Healthcare products Regulatory Agency said that patient information leaflets for gabapentinoids, benzodiazepines and z-drugs will include clearer definitions of dependence and addiction.…
